Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Choosing an IRA index fund matters for tax-advantaged growth; compare funds by fees, diversification, and track record to pick confidently.
22,995 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Altria sits around $73 with a near-6% yield, yet a from 52-week low: glaring risk and consumer softness raise questio...
The U.S. Housing and Urban Development Department unveiled a proposed rule to expand manufactured housing by allowing...
A large open-market sale by Indivior's Chief Scientific Officer sparked questions about future risk and long-term val...
FEZ investors see lumpy payouts tied to eurozone dividend calendars. This piece breaks down what that means for incom...
A chilling phone scam uses fear of an arrest to push immediate payments. Learn the telltale signs, how to respond saf...
A quiet revolution is unfolding in AI infrastructure. This article explains why the stock market underestimating mass...
Micron Technology has delivered a stunning 770% year-to-date surge as AI-driven memory demand intensifies. The rally ...
A multi-billion energy bill tied to Iran tensions is spurring Europe to accelerate new energy routes and trade corrid...
Beazer Homes priced a new debt issue, extending maturities and boosting liquidity, but the refinancing introduces a s...
Meta Platforms is pouring billions into AI infrastructure. This piece breaks down why that spending could pay off for...
As AI accelerates, the question on many investors' minds is will Nvidia stock soar. This article breaks down the driv...